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Ulceration is an important prognostic factor in melanoma whose biologic basis is poorly understood. Here we
assessed the prognostic impact of pleckstrin homology domain-interacting protein (PHIP) copy number and its
relationship to ulceration. PHIP copy number was determined using fluorescence in situ hybridization (FISH) in a
tissue microarray cohort of 238 melanomas. Elevated PHIP copy number was associated with significantly reduced
distant metastasis-free survival (DMFS; P¼ 0.01) and disease-specific survival (DSS; P¼ 0.009) by Kaplan–Meier
analyses. PHIP FISH scores were independently predictive of DMFS (P¼ 0.03) and DSS (P¼ 0.03). Increased PHIP
copy number was an independent predictor of ulceration status (P¼ 0.04). The combined impact of increased
PHIP copy number and tumor vascularity on ulceration status was highly significant (Po0.0001). Stable
suppression of PHIP in human melanoma cells resulted in significantly reduced glycolytic activity in vitro, with
lower expression of lactate dehydrogenase 5, hypoxia-inducible factor 1 alpha subunit, and vascular endothelial
growth factor, and was accompanied by reduced microvessel density in vivo. These results provide further
support for PHIP as a molecular prognostic marker of melanoma, and reveal a significant linkage between PHIP
levels and ulceration. Moreover, they suggest that ulceration may be driven by increased glycolysis and
angiogenesis.
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INTRODUCTION
Melanoma is an important clinical problem, with an estimated
76,250 new cases and 9,180 deaths in 2012 (Siegel et al.,
2012). The clinical behavior of melanoma can be unpre-
dictable, making prognostic predictions difficult in individual
patients. Although tumor thickness consistently emerges as the
single most significant prognostic factor determining survival,
and while ulceration increases the risk of death within a given
thickness range, additional factors are required to refine the
prognostic assessment of melanoma patients. Beyond histolo-
gical factors that are reliably associated with decreased
survival, molecular markers represent the next frontier in the
evaluation of melanoma outcome. Despite the identification
of numerous putative molecular prognostic factors, no
prognostic biomarkers are routinely used in the evaluation
of melanoma patients (Gogas et al., 2009). In addition, few
biomarkers have been shown to retain prognostic impact,
when measured on more than one platform (i.e., measure-
ments at the DNA vs. RNA vs. protein level).
Recent studies performed by our group identified a
previously unknown role for the pleckstrin homology
domain-interacting protein (PHIP) in melanoma progression
(De Semir et al., 2012). PHIP was identified as the top gene
overexpressed in metastatic versus primary melanomas
by gene expression profiling analysis (Haqq et al., 2005).
Short hairpin RNA (shRNA)-mediated suppression of PHIP
resulted in significant suppression of melanoma cell invasion
and metastatic potential in both murine and melanoma
cell lines. High levels of PHIP expression were associated
with significantly reduced survival in both mouse models
and human tissues. Specifically, high PHIP expression
(as determined by immunohistochemical analysis) was
independently predictive of distant metastasis-free survival
(DMFS) and disease-specific survival (DSS). In this study, we
analyze the role of PHIP copy number for its prognostic
significance in primary cutaneous melanoma and explore the
linkage between PHIP levels and ulceration development in
melanoma.
See related commentary on pg 600 ORIGINAL ARTICLE
1Center for Melanoma Research and Treatment, California Pacific Medical
Center and Research Institute, San Francisco, California, USA and 2UCSF
Helen Diller Family Comprehensive Cancer Center, San Francisco, California,
USA
Correspondence: Mohammed Kashani-Sabet, California Pacific Medical Center
Research Institute, 475 Brannan Street, Suite 220, San Francisco, California
94107, USA. E-mail: kashani@cpmcri.org
3These authors contributed equally to this work.
Received 11 April 2013; revised 11 August 2013; accepted 12 August 2013;
accepted article preview online 4 September 2013; published online
10 October 2013
Abbreviations: CD31, cluster of differentiation 31; DMFS, distant metastasis-
free survival; DSS, disease-specific survival; FISH, fluorescence in situ
hybridization; HIF1A, hypoxia-inducible factor 1 alpha subunit; LDH5, lactate
dehydrogenase 5; PHIP, pleckstrin homology domain-interacting protein;
shRNA, short hairpin RNA; TMA, tissue microarray; VEGF, vascular
endothelial growth factor
& 2014 The Society for Investigative Dermatology www.jidonline.org 783
RESULTS
Given the recent demonstration of a significant prognostic role
for PHIP protein expression and the presence of elevated PHIP
copy number in melanoma (De Semir et al., 2012), we aimed
to determine the prognostic impact of PHIP copy number
in primary cutaneous melanoma. PHIP copy number was
analyzed using fluorescence in situ hybridization (FISH) on a
tissue microarray (TMA) cohort of 238 specimens, with known
immunohistochemical analysis of PHIP protein expression, by
an observer blinded to patient outcomes. Overall, 22% of the
cohort possessed a mean copy number of 3 or greater. See
Figure 1a for representative examples of low versus high PHIP
copy number. As the ratio of PHIP and probes representing the
centromere of chromosome 6 in almost all of the cases was
close to 1.0 (Supplementary Table S1 online), the primary
attribute assessed was percentage of cells expressing three or
more copies of the PHIP gene, in which there was a range
from 0 to 87%, with a mean of 33.4%. There was a significant
correlation between PHIP copy number and level of expres-
sion of the PHIP protein (Po0.0001, Supplementary Figure S1
online).
Initially, we analyzed the relationship between PHIP copy
number and melanoma outcome using univariate analysis.
High PHIP copy number was associated with decreased
melanoma survival, when DMFS (P¼ 0.01 by log-rank test)
and DSS (P¼0.009 by log-rank test) were assessed using
Kaplan–Meier analysis (Figure 1b and c). In addition, there
was a significantly increased risk of distant metastasis or death
due to melanoma with the presence of high PHIP FISH scores.
In all, 45.4% of patients with high copy number had distant
metastasis, when compared with 25.5% with low copy
number (Fisher’s exact test, P¼0.015). In total, 42.2% of
patients with high copy number died of metastatic melanoma,
when compared with 17.7% of patients with low copy
number (Fisher’s exact test, Po0.002).
Next, we examined the relationship between PHIP copy
number and survival using multivariate Cox regression analy-
sis. High PHIP FISH scores were significantly predictive of
reduced DMFS (P¼0.03, Table 1) and DSS (P¼ 0.027,
Table 2) in multivariate models that included tumor thickness,
ulceration, age, gender, and tumor site. Thus, PHIP copy
number was independently predictive of survival associated
with melanoma, similar to the results obtained for PHIP
protein expression (De Semir et al., 2012).
Recently, high PHIP immunohistochemical scores were
shown to correlate with ulceration status (De Semir et al.,
2012). We aimed to confirm this relationship at the DNA
level. High PHIP copy number was significantly associated
with ulceration status when analyzed by univariate logistic
regression analysis (P¼0.004). In addition, high PHIP copy
number was associated with a significantly increased risk of
developing ulceration. Thus, ulceration was present in 45.5%
of cases with high PHIP copy number, when compared with
28.8% of cases with low PHIP copy number (P¼0.013,
Fisher’s exact test).
Previously, we reported that ulceration was associated
with increased tumor vascularity in the primary tumor,
when assessed morphologically (Kashani-Sabet et al., 2002).
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Figure 1. Pleckstrin homology domain-interacting protein (PHIP) copy number and its correlation with distant metastasis-free survival (DMFS) and
disease-specific survival (DSS) in melanoma patients. (a) Dual color fluorescence in situ hybridization (FISH) for PHIP locus (red) and centromere of
chromosome 6 (green) representative of low PHIP copy number (left panel) and high copy number (right panel). Scale bar¼ 20mm. (b) Kaplan–Meier analysis of
DMFS in patients with low PHIP copy number (curve 1) versus patients with high PHIP copy number (curve 2). (c) Kaplan–Meier analysis of DSS in patients with
low PHIP copy number (curve 1) versus patients with high PHIP copy number (curve 2).
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Elevated tumor vascularity (as determined by melanomas with
prominent vs. all lower degrees of vascularity) was signi-
ficantly associated with ulceration status. Ulceration was
present in 60.3% of the cases with prominent tumor
vascularity, when compared with 22.2% of cases with lower
degrees of tumor vascularity (Po0.0001, Fisher’s exact test).
This served to confirm the previously reported results in this
TMA cohort. We then explored the combined impact of high
PHIP copy number and elevated tumor vascularity on the
development of ulceration. Ulceration was present in 20.2%
of melanomas with both low PHIP copy number and low
tumor vascularity. This increased to 38.8% of cases ulcerated
with either prognostic factor elevated, and to 72.2% of
melanomas ulcerated, when both factors were elevated
(Po0.0001, w2 test of percentage differences).
We then assessed the relationship between PHIP copy
number and ulceration status, using multivariate logistic
regression analysis. Presence of ulceration in melanoma is
also known to increase both with increasing tumor thick-
ness and with increasing mitotic rate (Balch et al., 2001b;
Thompson et al., 2011). A multivariate logistic regression
analysis was performed, including low versus high PHIP
copy number, low versus high tumor vascularity, tumor
thickness, and mitotic rate. All four factors were significantly
predictive of the incidence of ulceration (Table 3). Thus,
PHIP FISH scores were independently predictive of
ulceration status, even with the inclusion of these other
factors (P¼ 0.04).
Next, we explored cellular pathways regulated by PHIP
expression potentially relevant to the development of ulcera-
tion. Targeted suppression of PHIP (using an anti-PHIP shRNA)
in C8161.9 human melanoma cells (with elevated PHIP copy
number) was previously shown to significantly suppress
melanoma cell invasiveness and metastatic potential (De
Semir et al., 2012). Given that PHIP functions in the IGF1
receptor pathway that is important in regulating glucose
metabolism, we assessed whether suppression of PHIP
activity resulted in altered glycolytic activity of melanoma
cells. C8161.9 cells expressing the anti-PHIP shRNA produced
significantly lower amounts of lactate than control cells
expressing a shRNA targeting luciferase (anti-luciferase
shRNA; Figure 2a). This was associated with decreased
expression of lactate dehydrogenase 5 (LDH5), the most
efficient isoenzyme of lactate dehydrogenase, which catalyzes
the conversion of pyruvate to lactate in the final step of
glycolysis (Figure 2b). In addition, culturing anti-PHIP shRNA-
expressing cells in the presence of methylpyruvate, which
bypasses glycolysis and directly enters the Krebs cycle,
resulted in significantly increased invasion (Figure 2c). Thus,
the pro-invasive role of PHIP in melanoma is mediated, at
least in part, by activating the glycolytic pathway. Moreover,
C8161.9 melanoma cells with reduced PHIP expression
produced lower levels of vascular endothelial growth factor
(VEGF), as determined by an ELISA assay of human VEGF
secretion (Figure 2d). As VEGF expression is controlled by
hypoxia-inducible factor 1 alpha subunit (HIF1A; Forsythe
et al., 1996), melanoma cells with suppressed PHIP expression
were also shown to express lower levels of HIF1A by western
analysis (Figure 2b).
Finally, we assessed the effects of suppression of PHIP on
the angiogenic potential of human melanoma cells in vivo.
C8161.9 melanoma cells were inoculated subcutaneously
into nude mice, and the resultant tumors examined for
microvessel density using immunofluorescence of CD31
positivity. Although there was no significant difference in
the tumor volume between the two groups (data not shown),
tumors in the anti-PHIP shRNA-expressing group (Figure 3a,
right panel) exhibited large areas of necrosis when compared
with the control group (Figure 3a, left panel). Analysis
of CD31 expression revealed that the control tumors
were characterized by large, abnormal blood vessels, and
Table 1. Cox regression analysis of impact of various
prognostic factors on DMFS of melanoma cohort
(N¼ 231)
Prognostic factor v2 Risk ratio P-value
Tumor thickness 6.96 1.38 0.008
High PHIP copy number 4.73 1.99 0.03
Ulceration 3.31 1.51 0.07
Sex 1.41 1.34 0.24
Site 0.92 1.24 0.34
Age 0.61 0.95 0.44
Abbreviations: DMFS, distant metastasis-free survival; PHIP, pleckstrin
homology domain-interacting protein.
Table 2. Cox regression analysis of impact of various
prognostic factors on DSS of melanoma cohort
(N¼ 231)
Prognostic factor v2 Risk ratio P-value
Tumor thickness 6.13 1.38 0.013
High PHIP copy number 4.87 2.21 0.027
Ulceration 3.63 1.58 0.057
Sex 1.00 1.30 0.32
Site 0.81 1.24 0.37
Age 0.01 0.99 0.91
Abbreviations: DSS, disease-specific survival; PHIP, pleckstrin homology
domain-interacting protein.
Table 3. Logistic regression analysis of impact of
various prognostic factors on incidence of ulceration in
melanoma cohort (N¼ 228)
Prognostic factor v2 Odds ratio P-value
Mitotic rate 15.24 1.23 0.0001
Tumor vascularity 10.26 3.05 0.001
Tumor thickness 5.99 1.63 0.01
High PHIP copy number 4.10 1.96 0.04
Abbreviation: PHIP, pleckstrin homology domain-interacting protein.
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hemorrhage, apparent from autofluorescence of erythrocytes
and lipofuscin (Baschong et al., 2001; Figure 3b and c, left
panels). By contrast, the vessels in the anti-PHIP shRNA-
expressing tumors were smaller, with little or no hemorrhage
evident (Figure 3b and c, right panels). Finally, the anti-PHIP
shRNA-expressing tumors had significantly reduced micro-
vessel density when compared with the control tumors
(Po0.02 as assessed both by a T-test and by a two-sample
randomization test, Figure 3d). Thus, increasing PHIP expres-
sion in human melanoma cells promotes angiogenic
potential.
DISCUSSION
In this article, we describe a previously unreported role for
PHIP copy number in the prognosis associated with mela-
noma. PHIP FISH scores were predictive of a significantly
increased risk of both distant metastasis and death due to
melanoma, and were independently predictive of DMFS and
DSS. In addition, elevated PHIP FISH scores were associated
with a higher incidence of ulceration and were independently
predictive of ulceration status. The combined impact of PHIP
copy number and tumor vascularity was additive, as cases
with high levels of both factors had a significantly higher
incidence of ulceration than cases with low levels of either or
both factors. Finally, C8161.9 human melanoma cells with
suppressed PHIP expression exhibited reduced glycolytic
activity and angiogenic potential.
These results provide further support for the role of PHIP
as a molecular prognostic marker for melanoma, as initially
described using immunohistochemical analysis of PHIP
expression. High PHIP protein expression was associated with
a significantly increased risk of distant metastasis and death
due to melanoma, and was independently predictive of DMFS
and DSS (De Semir et al., 2012). Our analysis of PHIP copy
number parallels the results obtained in human and murine
melanoma cell lines, in which suppressed PHIP expression
resulted in significantly reduced metastatic potential and
increased survival in xenograft models.
To date, few markers have been shown to provide sig-
nificant prognostic impact in melanoma when assessed on
more than one platform. For example, SPP1 expression has
been shown to have independent prognostic significance
when assessed at the RNA and protein levels (Rangel et al.,
2008; Conway et al., 2009). Our studies have demonstrated
a significant prognostic role for PHIP at both the DNA and
protein levels. Although the ratio of PHIP to chromosome 6
centromeric probe was close to 1.0 in the great majority of
cases examined, changes in PHIP copy number, ranging from
euploidy to three or greater copies, were highly correlated
with increased PHIP expression. Additional studies of PHIP
levels will be required in distinct cohorts in order to further
validate its prognostic role.
Beyond an independent impact on survival, these
studies confirmed a significant and independent relation-
ship between PHIP levels and ulceration status. In addi-
tion, PHIP copy number combined markedly with tumor
vascularity to increase the incidence of ulceration in
primary melanoma specimens. Ulceration is an important
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Figure 2. Effects of short hairpin RNA (shRNA)-mediated suppression of pleckstrin homology domain-interacting protein (PHIP) in human melanoma cells.
(a) Lactate production in C8161.9 cells expressing anti-PHIP shRNA versus control cells expressing anti-luciferase (anti-luc) shRNA. Mean±SE; N¼ 3.
*Denotes Po0.003. (b) Western analysis of lactate dehydrogenase 5 (LDH5) and hypoxia-inducible factor 1 alpha subunit (HIF1A) in C8161.9 cells expressing
anti-luc shRNA (control cells, lane 1) or anti-PHIP shRNA (lane 2). (c) Invasive capacity of C8161.9 stable transformants expressing anti-PHIP shRNA with
or without the addition of methylpyruvate (MP). Mean±SE; N¼3. *Denotes Po0.05. (d) ELISA assay of human vascular endothelial growth factor (VEGF)
levels produced by C8161.9 cells expressing anti-PHIP shRNA versus control cells expressing anti-luc shRNA. Mean±SE; N¼3. *Denotes Po0.0001.
GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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prognostic factor that has been incorporated into the American
Joint Committee on Cancer staging classification for mela-
noma for over a decade (Balch et al., 2001a, 2009). More
recently, ulceration has been suggested as a potential
predictive marker of benefit to adjuvant IFN alpha therapy
(McMasters et al., 2010; Eggermont et al., 2012). However,
the biologic basis for the development of ulceration is poorly
understood.
Increasing incidence of ulceration in melanoma is asso-
ciated with increasing tumor thickness, mitotic rate, and
tumor vascularity (Balch et al., 2001b; Kashani-Sabet et al.,
2002; Thompson et al., 2011). In addition, gene expression
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Figure 3. Effects of pleckstrin homology domain-interacting protein (PHIP) expression on the angiogenic potential of C8161.9 human melanoma cells in vivo.
(a) Representative images of hematoxylin and eosin (H&E) staining of subcutaneous tumors in nude mice. The left panel shows the growth pattern of C8161.9
cells expressing anti-luciferase (anti-luc) short hairpin RNA (shRNA), compared with C8161.9 cells expressing anti-PHIP shRNA (right panel). (b) Composite
images of immunofluorescence detection of CD31 (red) and 4,6-diamidino-2-phenylindole (DAPI; blue) as counterstain. The left panel shows the staining pattern
of CD31 in subcutaneous tumor with C8161.9 cells expressing anti-luc shRNA compared with C8161.9 cells expressing anti-PHIP shRNA (right panel).
Scale bar¼100mm. (c) Composite images of CD31 staining pattern with higher magnification for tumors with C8161.9 cells expressing anti-luc shRNA (left panel),
or anti-PHIP shRNA (right panel). Scale bar¼ 20mm. (d) Quantification of microvessel density (MVD) based on CD31 immunofluorescence positivity in tumors
(six per group) with C8161.9 cells expressing either anti-luc shRNA or anti-PHIP shRNA. Mean±SD. *Denotes Po0.02.
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profiling studies have identified a gene signature that
correlates with ulceration (Winnepenninckx et al., 2006).
However, the specific cellular pathways and mechanisms by
which ulceration develops are unclear. The linkage between
PHIP levels and ulceration implies a role for the IGF1
receptor pathway in ulceration, given PHIP’s involvement in
this signal transduction pathway. In addition, our studies in
human melanoma cells demonstrating that downregulation of
PHIP expression results in significantly reduced glycolytic
activity, VEGF secretion, and microvessel density provide
mechanistic insights, identifying glucose metabolism and
tumor angiogenesis as pathways by which ulceration may
develop in melanoma.
Tumor cell growth is promoted by increased glucose
consumption, a phenomenon known as the Warburg effect
(Warburg 1956). The importance of glycolysis to melanoma
progression has been amply reported in melanoma cell lines
(Halaban et al., 1997, 2002; Bagheri et al., 2006) and is
demonstrated clinically by the utility of positron emission
tomography scanning in the radiologic assessment of
melanoma both during initial staging (Reinhardt et al., 2006;
Falk et al., 2007) and in response to targeted therapy
(McArthur et al., 2012). Glycolysis in tumor cells is driven
by AKT (Elstrom et al., 2004), and PHIP is a potent activator of
AKT in melanoma (De Semir et al., 2012). Moreover,
increased glucose metabolism can itself drive tumor angio-
genesis, invasion, and metastasis (Lay et al., 2000; Tsutsumi
et al., 2004). Thus, our studies on PHIP in melanoma describe
a previously unreported link between PHIP, the Warburg
effect, tumor angiogenesis, and ulceration development. As
PHIP is activated through increased copy number in a subset
of melanomas, additional markers of ulceration will need
to be identified in melanomas without PHIP activation.
However, the mechanistic analyses provided here should
facilitate the identification of these additional markers in
distinct molecular subsets of melanoma patients.
Finally, our investigation of PHIP in melanoma tissues and
cell lines suggests an intriguing link between ulceration and
LDH levels. These results imply that a common tumor-
promoting pathway (i.e., IGF1 receptor), resulting in
increased glycolysis, may underlie the biologic basis of two
prominent prognostic markers incorporated into the American
Joint Committee on Cancer staging classification, one that
refines the prognosis of localized melanoma, the other the
prognosis of disseminated melanoma. Elevated LDH5 expres-
sion in primary melanoma has been previously shown to be
associated with reduced survival on univariate analysis, but
was not independently predictive of melanoma outcome
(Zhuang et al., 2010). Furthermore, LDH activity has been
correlated to HIF1A expression and angiogenic potential
(Koukourakis et al., 2003). However, further studies will be
required in order to confirm the link between ulceration and
LDH levels suggested by this analysis. In addition, high levels
of angiopoietin-2 have been reported in multiple cancers,
with a possible prognostic role (Bonner and Arbiser 2012),
and are accompanied by upregulation of RAS-related C3
botulinum toxin substrate signaling pathways (Felcht et al.,
2012). Thus, it is possible that elevated PHIP copy number
can modulate angiopoietin levels in melanoma, in part
through mitrochondrial dysfunction, nicotinamide adenine
dinucleotide phosphate oxidase induction, and increased
generation of reactive oxygen species (which result in angio-
poietin-2 activation). In conclusion, our studies support an
important role for PHIP as a molecular marker of melanoma
ulceration, metastasis and survival, and provide insights into
the cellular pathways through which ulceration can develop.
MATERIALS AND METHODS
Study population
This study used a TMA cohort that was previously described
according to REMARK guidelines (Rangel et al., 2006; Kashani-
Sabet et al., 2009). The molecular prognostic factor analyses
performed herein were approved by the appropriate ethics boards
both at CPMC and UCSF.
Fluorescence in situ hybridization
FISH was performed as previously described (Wiegant and Raap
2001; Chin et al., 2003; De Semir et al., 2012) using bacterial
artificial chromosome clones RP11-767O1, RP11-484L10, RP11-
217L13, and CTD-2297E14 to detect the PHIP locus and clones
RP11-26M18 and RP11-136K2 to detect 6q11.1 and 6p11.1
respectively (February 2009 freeze of the UCSC Genome Browser,
http://genome.ucsc.edu). Bacterial artificial chromosome DNA’s were
prepared with the Large-Construct kit (Qiagen, Valencia, CA) and
labeled by nick translation with Alexa Fluor 488 and 594 dUTPs (Life
Technologies, Grand Island, NY) as described (Wiegant and Raap
2001). The quality and mapping of all probes were verified by
hybridization to normal metaphase spreads in combination with a
commercially available centromeric probe for chromosome 6 (Open
Biosystems, Lafayette, CO) before tissue analysis. Hybridization on
TMA’s was performed as described previously (Wiegant and Raap
2001; Chin et al., 2003). Images were taken with a Zeiss Axio Imager
Z2 controlled by AxioVision software (Zeiss, Jena, Germany). The
FISH signals were assessed and counted manually from images with
several Z stack layers acquired using a Zeiss Axio Image Z2
microscope controlled by AxioVision software (Zeiss, Jena,
Germany). At least 30 nuclei from each case were evaluated, and
the signals were interpreted according to guidelines described
previously (Bayani and Squire 2004) and recorded as 1 through 5
or greater. Signals from bacterial artificial chromosome clones
detecting 6q11.1 and 6p11.1 were interpreted as the centromeric
signal for chromosome 6 and the count was used as control.
Cell culture studies
C8161.9 human melanoma cells stably expressing anti-PHIP shRNA
and anti-luciferase shRNA were generated and propagated as
described (De Semir et al., 2012). Lactate production and invasion
into matrigel were assayed as reported (De Semir et al., 2012).
C8161.9 cells were treated with 10 mM methylpyruvate (Sigma,
St Louis, MO) for 48 hours before the invasion assay. VEGF secre-
tion was measured by using an ELISA kit following the manufacturer’s
instructions (DY293B, R&D Systems, Minneapolis, MN). Western
blotting was performed as described (De Semir et al., 2012) using
antibodies targeting HIF1A (ab16066, Abcam, Minneapolis, MN),
LDH5 (ab1015, Abcam), and GAPDH (MAB374, Millipore,
Billerica, MA).
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Immunofluorescence
Groups of six nu/nu mice were inoculated subcutaneously with
1 million C8161.9 human melanoma cells expressing either control
luc or anti-PHIP shRNA. On day 25, the mice were sacrificed and the
tumors were assessed for microvessel density based on CD31 positi-
vity by immunofluorescence, which was performed using a rabbit
anti-CD31 antibody (ab28364, Abcam) and a secondary antibody
labeled with Alexa Fluor 594 (Life Technologies) as described
previously (Jalas et al., 2011). Mosaic images were acquired with
 20 magnification at a fixed exposure with a Zeiss Axio Imager Z2
microscope controlled by AxioVision software. After automatically
stitching the images, the number of CD31-positive objects and area
were determined using ImageJ software (NIH, Bethesda, MD). The
number of CD31-positive vessels was quantitated and the microvessel
density reported as the total CD31 count over the entire area of the
tumor.
Statistical analysis
Statistical methods used to assess the significance of various
prognostic factors on melanoma outcome were previously
described (Rangel et al., 2006; Kashani-Sabet et al., 2009). The
coding for clinical or pathological attributes was performed as
described by the AJCC staging committee for melanoma (Balch
et al., 2001b). The correlation between PHIP copy number and
immunohistochemical score was tested by regression analysis
using Data Desk software (Data Description, Ithaca, NY). For
both DMFS and DSS, the definition of high PHIP FISH scores, as
measured by percentage of cells harboring three or more copies
of PHIP, was established as equal to or greater than 16%.
A 16% cutoff served to maximize the average of the
sensitivity and specificity in the prediction of both DMFS and
DSS, analyzed separately. The same 16% cutoff was then
uniformly and consistently used in all subsequent analyses of
DMFS and DSS. The association between high PHIP copy
number and DMFS or DSS was assessed using both Kaplan–
Meier analysis and multivariate Cox regression. The association
between high PHIP copy number and presence or absence of
ulceration was assessed using both Fisher’s exact test and
multivariate logistic regression analysis. The association between
a high degree of tumor vascularity and ulceration was also
assessed using both Fisher’s exact test and multivariate logistic
regression. Assessment of the differential impacts of neither, either,
and both of these two factors was done using both w2 analysis and
Fisher’s exact test. In predicting ulceration status, high PHIP copy
number was uniformly defined as X35% of tumor cells harboring
three or more copies of the PHIP gene. This cutoff was similarly
selected as the one that maximized the average of sensitivity
and specificity in predicting ulceration. All P-values reported are
two sided.
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